about
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1-6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance.Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'.Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus.Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care.Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy.PTC725, an NS4B-Targeting Compound, Inhibits a Hepatitis C Virus Genotype 3 Replicon, as Predicted by Genome Sequence Analysis and Determined ExperimentallyOn-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir.
P2860
Q34467208-983BDC6E-A326-44DE-91E0-6995612EEBD9Q35172318-72E40610-5282-45CA-9700-BF4A704512C4Q35538245-8E87D246-65AB-4878-9D45-A33D76A19B3DQ35915999-7523C707-0B4C-41D1-B63A-ACABD8024D11Q36096436-F8F1A522-EFEE-48DD-8005-A5F9302BDE3FQ38249236-40889B49-B5E5-41AE-9702-68C43F30D133Q38844558-BE37A220-E26A-4764-B5FD-39596D0D5F68Q38980602-631EFC28-57C2-4CB7-9C85-16F8FF7528EDQ40398050-390FE53D-238A-4169-AA6A-5602EA845A0FQ40543016-E4694132-B952-428E-B5C1-9C940F68810CQ40671013-6021A792-DB07-406D-AA28-48B5BDB4FF68
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of hepatitis C virus genotype 3-infection.
@en
type
label
Treatment of hepatitis C virus genotype 3-infection.
@en
prefLabel
Treatment of hepatitis C virus genotype 3-infection.
@en
P2860
P356
P1433
P1476
Treatment of hepatitis C virus genotype 3-infection.
@en
P2093
Anaïs Vallet-Pichard
Marion Corouge
P2860
P356
10.1111/LIV.12405
P478
34 Suppl 1
P577
2014-02-01T00:00:00Z